Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/09/2010WO2010139069A1 Small molecule inhibitors of polynucleotide kinase/phosphatase. poly(adp-ribose) polymerase and uses thereof
12/09/2010WO2010117089A3 Antimycotic pharmaceutical composition
12/09/2010WO2010115947A3 Prolonged-release alfa-lipoic acid
12/09/2010WO2010115836A4 Substituted piperidines as ccr3 antagonists
12/09/2010WO2010100060A3 Method for increasing endogenous plasmalogen levels in mammals
12/09/2010WO2010096677A3 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
12/09/2010WO2010095858A3 Pharmaceutical composition containing rhei rhizoma extract, fractions thereof, or stilbene-based compounds for preventing or treating diseases mediated by intercellular adhesion molecule-1
12/09/2010WO2010091386A3 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/09/2010WO2010084499A9 Bicyclic heterocyclic spiro compounds
12/09/2010WO2010083239A3 Therapeutic modulation of vaginal epithelium boundary lubrication
12/09/2010WO2010072807A3 Inhibitors of cystahionine beta synthase for preventing or treating neurotoxic or cognitive disorders
12/09/2010WO2010042152A3 Amorphous rotigotine transdermal system
12/09/2010WO2010020789A3 Medicament combination comprising alkaloids and a purine analog antiviral agent
12/09/2010WO2010002613A3 Method of making a dry powder pharmaceutical composition
12/09/2010WO2009142525A3 Capsulating system binding to nucleolin
12/09/2010WO2009137217A8 Therapeutic replenishment and enrichment of ocular surface lubrication
12/09/2010WO2009130469A8 Dna-pk inhibitors
12/09/2010WO2009127944A8 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
12/09/2010WO2009121519A8 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
12/09/2010US20100313286 G protein-related kinase mutants in essential hypertension
12/09/2010US20100313285 Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation
12/09/2010US20100313283 Uses of gdnf and gdnf receptor
12/09/2010US20100312525 Ribosome Structure and Protein Synthesis Inhibitors
12/09/2010US20100312328 Drug-delivery endovascular stent and method of forming the same
12/09/2010US20100311979 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
12/09/2010US20100311843 Compositions and methods for the treatment of glomerulonephritis
12/09/2010US20100311842 Use of 1-Phenyl-3-dimethylamino-propane Compounds for Treating Neuropathic Pain
12/09/2010US20100311841 Synthetic sphingolipid analogs
12/09/2010US20100311840 Oral formulations of bis(thiohydrazide amides)
12/09/2010US20100311839 Burst Drug Release Compositions
12/09/2010US20100311838 Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
12/09/2010US20100311837 Method for improving storage stability of glutathione
12/09/2010US20100311835 Cis-9, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases
12/09/2010US20100311834 Methods of treating hypertriglyceridemia
12/09/2010US20100311833 Physiological coolants based on lactoyl esters of menthyl lactate
12/09/2010US20100311832 Lactylates for the prevention and treatment of infections caused by gram positive bacteria in animals
12/09/2010US20100311831 Reduction of Sterols and Other Compounds from Oils
12/09/2010US20100311830 Menthol Replacement
12/09/2010US20100311829 Novel Therapeutic Uses of Beta-3 Adrenergic Receptor Agonist Derivatives in Particular to Modulate Apoptosis
12/09/2010US20100311828 Extracts of sclerocarya birrea
12/09/2010US20100311827 Chlorogenic acid derivatives and their use as anti-fungal agents
12/09/2010US20100311826 Cytotoxic xanthone compounds
12/09/2010US20100311825 Novel taxoid-based compositions
12/09/2010US20100311824 Modulation of forkhead box o1a expression
12/09/2010US20100311823 Agent for regulating bone formation
12/09/2010US20100311821 Synthetic vector
12/09/2010US20100311820 Nucleic acid modulators of glycoprotein vi
12/09/2010US20100311818 Diterpene modulator of macrophage phagosomal maturation
12/09/2010US20100311816 MCP-1 binding nucleic acids and use thereof
12/09/2010US20100311815 Mir-101 cancer markers
12/09/2010US20100311814 Modulation of stat5 expression
12/09/2010US20100311813 Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311811 Rna-mediated epigenetic regulation of gene transcription
12/09/2010US20100311810 Modulation of diacylglycerol acyltransferase 2 expression
12/09/2010US20100311809 Viral vector system, a composition comprising the viral vector system and its use
12/09/2010US20100311808 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES
12/09/2010US20100311807 Methods for identifying diabetes and obesity therapeutics
12/09/2010US20100311806 Novel polymorphic form of rotigotine and process for production
12/09/2010US20100311805 Combination of histone deacetylase inhibitors and radiation
12/09/2010US20100311804 Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
12/09/2010US20100311803 Method for reducing inflammatory responses and inflammation
12/09/2010US20100311802 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
12/09/2010US20100311800 Angiotensin ii receptor antagonists
12/09/2010US20100311799 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010US20100311798 2-aminooxazolines as taar1 ligands
12/09/2010US20100311797 Novel Compounds
12/09/2010US20100311796 method for the separation and purification of epothilones
12/09/2010US20100311795 1,3-dioxane carboxylic acids
12/09/2010US20100311794 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/09/2010US20100311793 Polymorphs of donepezil salts, preparation methods and uses thereof
12/09/2010US20100311792 Benzenesulfonamide Compounds and the Use Thereof
12/09/2010US20100311791 N-halogenated amino compounds and derivatives
12/09/2010US20100311789 3-Substituted Propanamine Compounds
12/09/2010US20100311788 Salts of Clopidogrel With Polyanions and Their Use for Manufacturing Pharmaceutical Formulations
12/09/2010US20100311787 Compounds for inflammation and immune-related uses
12/09/2010US20100311786 Mono- or bicyclic carboxylic acids as off-note blockers
12/09/2010US20100311785 Combination Therapy For Modulating The Human Sexual Response
12/09/2010US20100311784 Stereoselective process and crystalline forms of a camptothecin
12/09/2010US20100311783 Stereoselective process and crystalline forms of a camptothecin
12/09/2010US20100311782 Substituted piperidinylpropanoic acid compounds and methods of their use
12/09/2010US20100311781 Synthesis of r-n-methylnaltrexone
12/09/2010US20100311780 Nitric oxide amino acid ester compound, composition for increasing nitirc oxide levels and method of use
12/09/2010US20100311779 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311776 Novel sEH Inhibitors and their Use
12/09/2010US20100311775 Novel sEH Inhibitors and Their Use
12/09/2010US20100311774 Combination Comprising Paclitaxel for Treating Ovarian Cancer
12/09/2010US20100311773 Novel anabaseine derivatives, pharmaceutical compositions and methods of use thereof
12/09/2010US20100311772 Method and compounds for inhibition of cell death
12/09/2010US20100311771 Method of treating movement disorders using barbituric acid derivatives
12/09/2010US20100311770 Compound combinations for inhibiting cell division and methods for their identification and use
12/09/2010US20100311769 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
12/09/2010US20100311768 Use of purine derivatives for the manufacture of a medicament
12/09/2010US20100311767 Method for the treatment of amyloidoses
12/09/2010US20100311766 Antibacterial compositions
12/09/2010US20100311765 Metabolic degradation inhibitors for anti-hyperproliferative agents
12/09/2010US20100311764 Methods of using 4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds
12/09/2010US20100311763 Pyridazine derivatives and their use as therapeutic agents
12/09/2010US20100311762 Reduction of toxicity of multi-targeting antifolates
1 ... 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 ... 7860